Table 3. Different datasets to analyze the prognosis of PITX1 gene expression in breast cancer.
Dataset | Probe ID | End point | No. | Cox P-value | HR |
---|---|---|---|---|---|
GSE19615 | Distant Metastasis-Free Survival | 209587_at | 115 | 0.024727 | 2.56 [1.13–5.82] |
GSE19615 | Distant Metastasis-Free Survival | 208502_s_at | 115 | 0.045388 | 1.71 [1.01–2.89] |
GSE12276 | Relapse-Free Survival | 208502_s_at | 204 | 0.033187 | 1.12 [1.01–1.24] |
GSE11121 | Distant Metastasis-Free Survival | 209587_at | 200 | 0.022601 | 1.35 [1.04–1.76] |
GSE11121 | Distant Metastasis-Free Survival | 208502_s_at | 200 | 0.040643 | 1.28 [1.01–1.62] |
GSE1456-GPL96 | Relapse-Free Survival | 209587_at | 159 | 0.048027 | 1.37 [1.00–1.88] |
GSE1456-GPL96 | Relapse-Free Survival | 208502_s_at | 159 | 0.007207 | 1.37 [1.09–1.73] |
GSE1456-GPL96 | Disease-Specific Survival | 208502_s_at | 159 | 0.008357 | 1.46 [1.10–1.94] |
GSE1456-GPL96 | Disease-Specific Survival | 209587_at | 159 | 0.011151 | 1.65 [1.12–2.42] |
GSE3494-GPL96 | Disease-Specific Survival | 208502_s_at | 236 | 0.022379 | 1.24 [1.03–1.49] |